MARKET OUTLOOK

Global building integrated photovoltaics market is estimated to witness growth at a CAGR of 17.31% during the forecast period 2023-2030.
Factors such as the reduction of carbon footprint by BIPV panels, high energy demand, and rising government initiatives to standardize integrated PV products are driving the studied market’s growth. However, the slow growth of solar power across developing nations may impede its growth.
Nevertheless, the surge in rooftop solar systems, high efficiency and cost reduction of solar PV, and growing renewable energy investment are generating opportunities for the BIPV market.

REGIONAL OUTLOOK

The global BIPV market encompasses Asia-Pacific, North America, Latin America, Europe, and the Middle East and Africa regions.
Globally, the Asia-Pacific is estimated to arise as the fastest-growing region over the forecast period. The region’s growth is supported by the rising focus on developing renewable power. Moreover, robust economic growth and a growing population have generated prospects for renewable energy, prompting several investments in clean energy generation. Countries like China, Japan, and South Korea have adopted net-zero emission targets to be achieved by 2050. Such steps widen the overall scope of the building integrated photovoltaics market.

COMPETITIVE OUTLOOK

The notable companies in the BIPV market consist of AGC Inc, Heliatek, Waaree Energies Ltd, Tesla Inc, SunPower Corporation, ClearVue Technologies Limited, Saule Technologies, Kaneka Corporation, Ertex Solartechnik GmbH, and MetSolar.

Tesla Inc is engaged in building a world that is powered by solar energy. The company’s solar products are adopted by residential and commercial sectors. It spends around 5% of its revenue on R&D activities annually. Moreover, the company has installed around 480,000 roofs generating over 25 TWh of clean energy. Tesla has operations across the world, with headquarters located in the United States.

TABLE OF CONTENTS

1. GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET – SUMMARY

2. INDUSTRY OUTLOOK
2.1. PARENT MARKET ANALYSIS
2.2. IMPACT ANALYSIS ON THE BUILDING INTEGRATED PHOTOVOLTAICS MARKET
2.2.1. COVID-19 IMPACT ON THE BUILDING INTEGRATED PHOTOVOLTAICS MARKET
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET MATURITY ANALYSIS
2.5. INDUSTRY COMPONENTS
2.5.1. COMPONENT MANUFACTURER
2.5.2. BUILDING INTEGRATED PHOTOVOLTAIC MANUFACTURERS
2.5.3. END-USERS
2.6. REGULATORY FRAMEWORK
2.7. KEY BUYING ANALYSIS
2.7.1. SUPERIOR TECHNOLOGY
2.7.2. APPLICATION
2.7.3. EFFICIENCY
2.7.4. RELIABILITY
2.8. KEY MARKET STRATEGIES
2.8.1. COLLABORATIONS
2.8.2. PRODUCT LAUNCHES
2.8.3. MERGERS & ACQUISITIONS
2.9. MARKET DRIVERS
2.9.1. REDUCTION OF CARBON FOOTPRINT BY BIPV PANELS
2.9.2. HIGH DEMAND FOR ENERGY
2.9.3. GROWING GOVERNMENT INITIATIVES TO STANDARDIZE INTEGRATED PHOTOVOLTAIC PRODUCTS FOR BUILDINGS
2.10. MARKET CHALLENGE
2.10.1. SLOW GROWTH OF SOLAR ENERGY ACROSS DEVELOPING NATIONS
2.11. MARKET OPPORTUNITIES
2.11.1. RISE IN ROOFTOP SOLAR SYSTEMS FOR HOMES AND BUSINESSES
2.11.2. HIGH EFFICIENCY AND SIGNIFICANT COST REDUCTION IN THE SOLAR PV SEGMENT
2.11.3. RISING NEED FOR SUSTAINABLE AND CLEAN ENERGY
2.11.4. INCREASE IN RENEWABLE ENERGY INVESTMENT
2.12. ANALYST PERSPECTIVE

3. GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET – BY TECHNOLOGY
3.1. CRYSTALLINE SILICON
3.1.1. MONOCRYSTALLINE
3.1.2. POLYCRYSTALLINE
3.2. THIN FILM
3.3. OTHER TECHNOLOGIES

4. GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET – BY APPLICATION
4.1. ROOFING
4.2. GLAZING
4.3. FACADES
4.4. ARCHITECTURAL SHADING

5. GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET – BY INDUSTRY VERTICAL
5.1. INDUSTRIAL
5.2. COMMERCIAL
5.3. RESIDENTIAL

6. GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET – BY REGIONAL OUTLOOK
6.1. NORTH AMERICA
6.1.1. MARKET BY TECHNOLOGY
6.1.1.1. MARKET BY CRYSTALLINE SILICON
6.1.2. MARKET BY APPLICATION
6.1.3. MARKET BY INDUSTRY VERTICAL
6.1.4. COUNTRY ANALYSIS
6.1.4.1. UNITED STATES
6.1.4.1.1. UNITED STATES BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.1.4.2. CANADA
6.1.4.2.1. CANADA BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.2. EUROPE
6.2.1. MARKET BY TECHNOLOGY
6.2.1.1. MARKET BY CRYSTALLINE SILICON
6.2.2. MARKET BY APPLICATION
6.2.3. MARKET BY INDUSTRY VERTICAL
6.2.4. COUNTRY ANALYSIS
6.2.4.1. GERMANY
6.2.4.1.1. GERMANY BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.2.4.2. UNITED KINGDOM
6.2.4.2.1. UNITED KINGDOM BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.2.4.3. FRANCE
6.2.4.3.1. FRANCE BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.2.4.4. ITALY
6.2.4.4.1. ITALY BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.2.4.5. SPAIN
6.2.4.5.1. SPAIN BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.2.4.6. POLAND
6.2.4.6.1. POLAND BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.2.4.7. NORDIC COUNTRIES
6.2.4.7.1. NORDIC COUNTRIES BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.2.4.8. REST OF EUROPE
6.2.4.8.1. REST OF EUROPE BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.3. ASIA-PACIFIC
6.3.1. MARKET BY TECHNOLOGY
6.3.1.1. MARKET BY CRYSTALLINE SILICON
6.3.2. MARKET BY APPLICATION
6.3.3. MARKET BY INDUSTRY VERTICAL
6.3.4. COUNTRY ANALYSIS
6.3.4.1. CHINA
6.3.4.1.1. CHINA BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.3.4.2. JAPAN
6.3.4.2.1. JAPAN BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.3.4.3. INDIA
6.3.4.3.1. INDIA BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.3.4.4. SOUTH KOREA
6.3.4.4.1. SOUTH KOREA BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.3.4.5. AUSTRALIA
6.3.4.5.1. AUSTRALIA BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.3.4.6. ASEAN COUNTRIES
6.3.4.6.1. ASEAN COUNTRIES BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.3.4.7. REST OF ASIA-PACIFIC
6.3.4.7.1. REST OF ASIA-PACIFIC BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.4. LATIN AMERICA
6.4.1. MARKET BY TECHNOLOGY
6.4.1.1. MARKET BY CRYSTALLINE SILICON
6.4.2. MARKET BY APPLICATION
6.4.3. MARKET BY INDUSTRY VERTICAL
6.4.4. COUNTRY ANALYSIS
6.4.4.1. BRAZIL
6.4.4.1.1. BRAZIL BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.4.4.2. MEXICO
6.4.4.2.1. MEXICO BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.4.4.3. ARGENTINA
6.4.4.3.1. ARGENTINA BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.4.4.4. CHILE
6.4.4.4.1. CHILE BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.4.4.5. REST OF LATIN AMERICA
6.4.4.5.1. REST OF LATIN AMERICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.5. MIDDLE EAST AND AFRICA
6.5.1. MARKET BY TECHNOLOGY
6.5.1.1. MARKET BY CRYSTALLINE SILICON
6.5.2. MARKET BY APPLICATION
6.5.3. MARKET BY INDUSTRY VERTICAL
6.5.4. COUNTRY ANALYSIS
6.5.4.1. UNITED ARAB EMIRATES
6.5.4.1.1. UNITED ARAB EMIRATES BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.5.4.2. SAUDI ARABIA
6.5.4.2.1. SAUDI ARABIA BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.5.4.3. SOUTH AFRICA
6.5.4.3.1. SOUTH AFRICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.5.4.4. EGYPT
6.5.4.4.1. EGYPT BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.5.4.5. TURKEY
6.5.4.5.1. TURKEY BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS
6.5.4.6. REST OF MIDDLE EAST AND AFRICA
6.5.4.6.1. REST OF MIDDLE EAST AND AFRICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET FORECAST & PROSPECTS

7. COMPETITIVE LANDSCAPE
7.1. AGC INC
7.1.1. OVERVIEW
7.1.2. FINANCIAL OVERVIEW
7.1.3. PRODUCT PORTFOLIO
7.1.4. KEY STRENGTHS
7.1.5. KEY CHALLENGES
7.2. HELIATEK
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY STRENGTHS
7.2.4. KEY CHALLENGES
7.3. CLEARVUE TECHNOLOGIES LIMITED
7.3.1. OVERVIEW
7.3.2. FINANCIAL OVERVIEW
7.3.3. PRODUCT PORTFOLIO
7.3.4. KEY STRENGTHS
7.3.5. KEY CHALLENGES
7.4. WAAREE ENERGIES LTD
7.4.1. OVERVIEW
7.4.2. FINANCIAL OVERVIEW
7.4.3. PRODUCT PORTFOLIO
7.4.4. KEY STRENGTHS
7.4.5. KEY CHALLENGES
7.5. KANEKA CORPORATION
7.5.1. OVERVIEW
7.5.2. FINANCIAL OVERVIEW
7.5.3. PRODUCT PORTFOLIO
7.5.4. KEY STRENGTHS
7.5.5. KEY CHALLENGES
7.6. TESLA INC
7.6.1. OVERVIEW
7.6.2. FINANCIAL OVERVIEW
7.6.3. PRODUCT PORTFOLIO
7.6.4. KEY STRENGTHS
7.6.5. KEY CHALLENGES
7.7. SUNPOWER CORPORATION
7.7.1. OVERVIEW
7.7.2. FINANCIAL OVERVIEW
7.7.3. PRODUCT PORTFOLIO
7.7.4. KEY STRENGTHS
7.7.5. KEY CHALLENGES
7.8. SAULE TECHNOLOGIES
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY STRENGTHS
7.8.4. KEY CHALLENGES
7.9. ERTEX SOLAR TECHNIK GMBH
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY STRENGTHS
7.9.4. KEY CHALLENGES
7.10. METSOLAR
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY STRENGTHS
7.10.4. KEY CHALLENGES

8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY REGIONAL OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATION
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF MERGERS & ACQUISITIONS
TABLE 6: KG/BILLIONS OF CO2 EMITTED PER MILLION BTU OF ENERGY, BY FUEL
TABLE 7: SHARE OF POPULATION WITH ACCESS TO ELECTRICITY IN 2020 (IN%)
TABLE 8: BUILDING-INTEGRATED PHOTOVOLTAIC (BIPV) PATENTS SHARE, BY COMPANY, 2021 (IN %)
TABLE 9: GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY TECHNOLOGY, 2023-2030 (IN $ MILLION)
TABLE 10: GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY CRYSTALLINE SILICON, 2023-2030 (IN $ MILLION)
TABLE 11: GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY APPLICATION, 2023-2030 (IN $ MILLION)
TABLE 12: GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY INDUSTRY VERTICAL, 2023-2030 (IN $ MILLION)
TABLE 13: GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY REGIONAL OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 14: NORTH AMERICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 15: NORTH AMERICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY TECHNOLOGY, 2023-2030 (IN $ MILLION)
TABLE 16: NORTH AMERICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY CRYSTALLINE SILICON, 2023-2030 (IN $ MILLION)
TABLE 17: NORTH AMERICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY APPLICATION, 2023-2030 (IN $ MILLION)
TABLE 18: NORTH AMERICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY INDUSTRY VERTICAL, 2023-2030 (IN $ MILLION)
TABLE 19: EUROPE BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 20: EUROPE BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY TECHNOLOGY, 2023-2030 (IN $ MILLION)
TABLE 21: EUROPE BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY CRYSTALLINE SILICON, 2023-2030 (IN $ MILLION)
TABLE 22: EUROPE BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY APPLICATION, 2023-2030 (IN $ MILLION)
TABLE 23: EUROPE BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY INDUSTRY VERTICAL, 2023-2030 (IN $ MILLION)
TABLE 24: NORDIC COUNTRIES RENEWABLE ENERGY CONSUMPTION SHARE IN 2005 & 2019 (IN % GROSS FINAL CONSUMPTION)
TABLE 25: ASIA-PACIFIC BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 26: ASIA-PACIFIC BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY TECHNOLOGY, 2023-2030 (IN $ MILLION)
TABLE 27: ASIA-PACIFIC BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY CRYSTALLINE SILICON, 2023-2030 (IN $ MILLION)
TABLE 28: ASIA-PACIFIC BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY APPLICATION, 2023-2030 (IN $ MILLION)
TABLE 29: ASIA-PACIFIC BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY INDUSTRY VERTICAL, 2023-2030 (IN $ MILLION)
TABLE 30: LATIN AMERICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 31: LATIN AMERICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY TECHNOLOGY, 2023-2030 (IN $ MILLION)
TABLE 32: LATIN AMERICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY CRYSTALLINE SILICON, 2023-2030 (IN $ MILLION)
TABLE 33: LATIN AMERICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY APPLICATION, 2023-2030 (IN $ MILLION)
TABLE 34: LATIN AMERICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY INDUSTRY VERTICAL, 2023-2030 (IN $ MILLION)
TABLE 35: MIDDLE EAST AND AFRICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 36: MIDDLE EAST AND AFRICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY TECHNOLOGY, 2023-2030 (IN $ MILLION)
TABLE 37: MIDDLE EAST AND AFRICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY CRYSTALLINE SILICON, 2023-2030 (IN $ MILLION)
TABLE 38: MIDDLE EAST AND AFRICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY APPLICATION, 2023-2030 (IN $ MILLION)
TABLE 39: MIDDLE EAST AND AFRICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY INDUSTRY VERTICAL, 2023-2030 (IN $ MILLION)
TABLE 40: AGC INC- COMPANY OPERATING EXPENSES & EBITDA IN 2019-2021 (IN $ BILLION)

FIGURE LIST

FIGURE 1: PARENT MARKET FLOWCHART FOR BIPV
FIGURE 2: MARKET MATURITY ANALYSIS
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: KEY BUYING ANALYSIS
FIGURE 5: BIPV STAKEHOLDERS’ ECOSYSTEM
FIGURE 6: PATENTS PUBLISHED ON BIPV TECHNOLOGIES 2017-2022 (NUMBER)
FIGURE 7: BIPV PATENT SHARES, BY ASSIGNEE COUNTRY, 2021 (%)
FIGURE 8: GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY TECHNOLOGY, 2022 & 2030 (IN %)
FIGURE 9: GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY CRYSTALLINE SILICON, 2023-2030 (IN $ MILLION)
FIGURE 10: GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY CRYSTALLINE SILICON, 2022 & 2030 (IN %)
FIGURE 11: GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY MONOCRYSTALLINE, 2023-2030 (IN $ MILLION)
FIGURE 12: GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY APPLICATION, 2022 & 2030 (IN %)
FIGURE 13: GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY ROOFING, 2023-2030 (IN $ MILLION)
FIGURE 14: GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY GLAZING, 2023-2030 (IN $ MILLION)
FIGURE 15: GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY FACADES, 2023-2030 (IN $ MILLION)
FIGURE 16: GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY ARCHITECTURAL SHADING, 2023-2030 (IN $ MILLION)
FIGURE 17: GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY INDUSTRY VERTICAL, 2022 & 2030 (IN %)
FIGURE 18: GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY INDUSTRIAL, 2023-2030 (IN $ MILLION)
FIGURE 19: GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY COMMERCIAL, 2023-2030 (IN $ MILLION)
FIGURE 20: GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY RESIDENTIAL, 2023-2030 (IN $ MILLION)
FIGURE 21: GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET, BY REGIONAL OUTLOOK, 2022 & 2030 (IN %)
FIGURE 22: UNITED STATES BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 23: CANADA BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 24: GERMANY BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 25: UNITED KINGDOM BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 26: FRANCE BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 27: ITALY BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 28: SPAIN BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 29: POLAND BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 30: NORDIC COUNTRIES BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 31: REST OF EUROPE BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 32: CHINA BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 33: JAPAN BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 34: INDIA BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 35: SOUTH KOREA BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 36: AUSTRALIA BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 37: ASEAN COUNTRIES BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 38: REST OF ASIA-PACIFIC BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 39: BRAZIL BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 40: MEXICO BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 41: ARGENTINA BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 42: CHILE BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 43: REST OF LATIN AMERICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 44: UNITED ARAB EMIRATES BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 45: SAUDI ARABIA BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 46: SOUTH AFRICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 47: EGYPT BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 48: TURKEY BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 49: REST OF MIDDLE EAST AND AFRICA BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 (IN $ MILLION)
FIGURE 50: AGC INC – COMPANY REVENUE IN 2019-2021 (IN $ BILLION)
FIGURE 51: AGC INC – COMPANY NET INCOME IN 2019-2021 (IN $ BILLION)
FIGURE 52: AGC INC – COMPANY REVENUE, BY REGION, IN 2021 (IN %)
FIGURE 53: CLEARVUE TECHNOLOGIES LIMITED – COMPANY REVENUE, IN 2019-2021 (IN $ MILLION)
FIGURE 54: WAAREE ENERGIES LTD – COMPANY REVENUE IN 2019-2021 (IN $ MILLION)
FIGURE 55: WAAREE ENERGIES LTD – COMPANY NET INCOME IN 2019-2021 (IN $ MILLION)
FIGURE 56: KANEKA CORPORATION – COMPANY REVENUE, IN 2019-2021 (IN $ MILLION)
FIGURE 57: KANEKA CORPORATION – COMPANY SALES, BY BUSINESS SEGMENT, IN 2021 (IN %)
FIGURE 58: KANEKA CORPORATION – COMPANY REVENUE, BY REGION, IN 2021 (IN %)
FIGURE 59: TESLA INC – COMPANY REVENUE, IN 2019-2021 (IN $ MILLION)
FIGURE 60: TESLA INC – COMPANY SALES, BY BUSINESS SEGMENT, IN 2021 (IN %)
FIGURE 61: TESLA INC – COMPANY REVENUE, BY REGION, IN 2021 (IN %)
FIGURE 62: SUNPOWER CORPORATION – COMPANY REVENUE IN 2019-2021 (IN $ MILLION)
FIGURE 63: SUNPOWER CORPORATION – COMPANY SALES, BY BUSINESS SEGMENT, IN 2021 (IN %)

The post GLOBAL BUILDING INTEGRATED PHOTOVOLTAICS MARKET 2023-2030 first appeared on CRI Report.

CRI’s report puts forth that the global clinical trials support services market would register growth at a CAGR of 7.84% during the forecast phase of 2022-2028.
The rise in the incidence of diseases has majorly increased the demand for clinical trials support services, which is expected to drive the market growth. Further, the efficiency of support services in overcoming the barriers encountered while conducting clinical trials is another key factor supporting growth.
On the other hand, the delays in receiving regulatory approval for carrying out clinical trials due to stringent regulations are hindering the growth process. Moreover, the disadvantages associated with the use of open-source software are also negatively impacting market progress.
However, the increasing demand for pharmaceuticals & vaccines, along with the growing number of strategic acquisitions by market players, are expected to open up new growth opportunities for the clinical trial support services market.

REGIONAL OUTLOOK

The global market for clinical trials support services encompasses North America, Europe, the Asia-Pacific, Latin America, and the Middle East and Africa.
North America is the leading region in the global market, and held the largest market share in 2021. Most key players in the clinical trials support services market, such as IQVIA, Parexel, and Charles River Laboratories, among others, are based in the United States. This largely benefits the North American market.
Whereas, the high population of the Asia-Pacific, especially Asia, adds an advantage to the market in this region. This is because researchers gain access to a large number of potential trial participants. The Asia-Pacific is expected to witness the fastest growth in the global market over the considered period.

COMPETITIVE OUTLOOK

The leading players profiled in the global clinical trials support services market report include Charles River Laboratories, Advanced Clinical, WuXi AppTec, Parexel, IQVIA, Clinipace, PSI CRO, Worldwide Clinical Trials, Labcorp Drug Development, KCR, ICON Plc, Alcura, Medpace, CTI Clinical Trial and Consulting Services Inc, and Syneos Health.
Worldwide Clinical Trials is a globally leading contract research organization (CRO) that is invested in various therapeutic areas, such as cardiovascular, oncology, neuroscience, metabolic, and rare disease.
It offers several services, such as early phase/phase I development, phase II b-III clinical trials, phase III b- phase IV clinical trials, etc. Biostatistics services offered by the organization comprise statistical analysis plan development, sample size estimation & methodology review, rapid reporting, and data delivery. Founded in 1986, Worldwide Clinical Trials has a business presence in North America, Asia-Pacific, Latin America, and Europe.

TABLE OF CONTENTS

1. GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE CLINICAL TRIALS SUPPORT SERVICES MARKET
2.2. KEY INSIGHTS
2.2.1. KEY PLAYERS’ PROMISING COLLABORATIONS
2.2.2. INCREASE IN SCREENING TESTS
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY BUYING IMPACT ANALYSIS
2.4.1. PERFORMANCE
2.4.2. EASE OF USE
2.4.3. SECURITY
2.4.4. COST EFFECTIVENESS
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. REGULATORY FRAMEWORK
2.9. KEY MARKET STRATEGIES
2.9.1. ACQUISITIONS
2.9.2. PRODUCT LAUNCHES
2.9.3. CONTRACTS & AGREEMENTS
2.9.4. INVESTMENTS & EXPANSIONS
2.10. MARKET DRIVERS
2.10.1. NEED TO OVERCOME THE BARRIERS IN CLINICAL TRIALS
2.10.2. RISE IN TRIALS DUE TO INCREASED DISEASE INCIDENCE
2.11. MARKET CHALLENGES
2.11.1. DELAYED APPROVAL DUE TO STRINGENT REGULATORY FRAMEWORK
2.11.2. USE OF OPEN-SOURCE SOFTWARE
2.12. MARKET OPPORTUNITIES
2.12.1. INCREASING DEMAND FOR VACCINES AND PHARMACEUTICALS
2.12.2. DATA MANAGEMENT SERVICE EXPECTED TO WITNESS NOTABLE GROWTH
2.12.3. ACQUISITIONS IN THE CLINICAL TRIALS SUPPORT SERVICES MARKET
3. GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY PHASE TYPE
3.1. PHASE I
3.2. PHASE II
3.3. PHASE III
3.4. PHASE IV
4. GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SERVICE
4.1. CLINICAL TRIAL SITE MANAGEMENT
4.2. ADMINISTRATIVE SERVICES
4.3. PATIENT RECRUITMENT MANAGEMENT
4.4. REGULATORY SERVICES
4.5. DATA MANAGEMENT
4.6. OTHER SERVICES
5. GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SPONSOR
5.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
5.2. MEDICAL DEVICE COMPANIES
5.3. OTHER SPONSORS
6. GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET – REGIONAL OUTLOOK
6.1. NORTH AMERICA
6.1.1. MARKET OUTLOOK BY SERVICE
6.1.2. MARKET OUTLOOK BY PHASE TYPE
6.1.3. MARKET OUTLOOK BY SPONSOR
6.1.4. COUNTRY ANALYSIS
6.1.4.1. UNITED STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET OUTLOOK BY SERVICE
6.2.2. MARKET OUTLOOK BY PHASE TYPE
6.2.3. MARKET OUTLOOK BY SPONSOR
6.2.4. COUNTRY ANALYSIS
6.2.4.1. UNITED KINGDOM
6.2.4.2. GERMANY
6.2.4.3. FRANCE
6.2.4.4. SPAIN
6.2.4.5. ITALY
6.2.4.6. REST OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET OUTLOOK BY SERVICE
6.3.2. MARKET OUTLOOK BY PHASE TYPE
6.3.3. MARKET OUTLOOK BY SPONSOR
6.3.4. COUNTRY ANALYSIS
6.3.4.1. CHINA
6.3.4.2. JAPAN
6.3.4.3. INDIA
6.3.4.4. SOUTH KOREA
6.3.4.5. ASEAN COUNTRIES
6.3.4.6. AUSTRALIA & NEW ZEALAND
6.3.4.7. REST OF ASIA-PACIFIC
6.4. LATIN AMERICA
6.4.1. MARKET OUTLOOK BY SERVICE
6.4.2. MARKET OUTLOOK BY PHASE TYPE
6.4.3. MARKET OUTLOOK BY SPONSOR
6.4.4. COUNTRY ANALYSIS
6.4.4.1. BRAZIL
6.4.4.2. MEXICO
6.4.4.3. REST OF LATIN AMERICA
6.5. MIDDLE EAST AND AFRICA
6.5.1. MARKET OUTLOOK BY SERVICE
6.5.2. MARKET OUTLOOK BY PHASE TYPE
6.5.3. MARKET OUTLOOK BY SPONSOR
6.5.4. COUNTRY ANALYSIS
6.5.4.1. UNITED ARAB EMIRATES
6.5.4.2. SAUDI ARABIA
6.5.4.3. TURKEY
6.5.4.4. SOUTH AFRICA
6.5.4.5. REST OF MIDDLE EAST & AFRICA
7. COMPETITIVE LANDSCAPE
7.1. IQVIA
7.2. PAREXEL
7.3. ICON PLC
7.4. SYNEOS HEALTH
7.5. LABCORP DRUG DEVELOPMENT
7.6. CLINIPACE
7.7. KCR
7.8. CHARLES RIVER LABORATORIES
7.9. MEDPACE
7.10. ALCURA
7.11. PSI CRO
7.12. WORLDWIDE CLINICAL TRIALS
7.13. CTI CLINICAL TRIAL AND CONSULTING SERVICES INC
7.14. WUXI APPTEC
7.15. ADVANCED CLINICAL
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: LIST OF COLLABORATIONS
TABLE 3: VENDOR SCORECARD
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: LIST OF ACQUISITIONS
TABLE 6: LIST OF PRODUCT LAUNCHES
TABLE 7: LIST OF CONTRACTS & AGREEMENTS
TABLE 8: LIST OF INVESTMENTS & BUSINESS EXPANSIONS
TABLE 9: LIST OF PANDEMIC OUTBREAKS
TABLE 10: LIST OF OPEN-SOURCE SOFTWARE
TABLE 11: LAUNCH OF MEDICAL DRUGS
TABLE 12: PROMISING ACQUISITIONS IN THE MARKET
TABLE 13: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 14: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 15: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 16: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 17: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 18: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 19: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 20: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 21: NUMBER AND TYPES OF REGISTERED STUDIES
TABLE 22: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 23: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 24: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 25: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 26: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 27: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 28: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 29: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 30: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 31: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 32: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 33: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 34: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 35: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 36: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 37: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2021 & 2028 (IN %)
FIGURE 5: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2028 (IN $ MILLION)
FIGURE 6: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2028 (IN $ MILLION)
FIGURE 7: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2028 (IN $ MILLION)
FIGURE 8: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2028 (IN $ MILLION)
FIGURE 9: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2021 & 2028 (IN %)
FIGURE 10: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 11: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 12: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 13: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGULATORY SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 14: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 15: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 16: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2021 & 2028 (IN %)
FIGURE 17: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 18: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 19: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2028 (IN $ MILLION)
FIGURE 20: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, REGIONAL OUTLOOK, 2021 & 2028 (IN %)
FIGURE 21: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 22: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: CANADA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 25: UNITED KINGDOM CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: GERMANY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 27: FRANCE CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 28: SPAIN CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 29: ITALY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 30: REST OF EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 31: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 32: CHINA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 33: JAPAN CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 34: INDIA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 35: SOUTH KOREA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 36: ASEAN COUNTRIES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 37: AUSTRALIA & NEW ZEALAND CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 38: REST OF ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 39: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 40: BRAZIL CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 41: MEXICO CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 42: REST OF LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 43: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 44: UNITED ARAB EMIRATES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 45: SAUDI ARABIA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 46: TURKEY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 47: SOUTH AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 48: REST OF MIDDLE EAST & AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

The post GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 first appeared on CRI Report.

Based on CRI’s report, the global companion diagnostics market is projected to progress with a CAGR of 12.84% during the forecast period 2022-2028.
The prominent factors fueling the global market’s growth include a surge in medication reaction incidence, increasing cancer cases, and the growing use of precision medicines. Additionally, the ongoing research and investments in next generation gene-sequencing are expected to create affluent opportunities for the market.
However, a weak reimbursement framework and common cases of leakage in oncology companion diagnostics are expected to restrict the studied market’s growth over the forecast period.

REGIONAL OUTLOOK

The global companion diagnostics market covers North America, Asia-Pacific, Latin America, Europe, and the Middle East and Africa regions.
The Asia-Pacific is anticipated to emerge as the fastest-growing region over the forecast period. The region’s growth can be attributed to the tremendous growth in precision medicine technology. Moreover, initiatives undertaken to promote the R&D of precision medicine are supporting the market’s growth. In this regard, diagnostic and pharma companies are collaborating to offer an international platform to facilitate access to precision medicine. Thus, as mentioned above, these factors are expected to widen the scope and growth of the companion diagnostics market in the upcoming years.

COMPETITIVE OUTLOOK

The prominent companies thriving in the companion diagnostics market are Sysmex Corporation, Almac Group, Arup Laboratories, Biocartis, Abbott Laboratories, bioMerieux, GE Healthcare, Genomic Health, Danaher Corporation, Illumina Inc, Myriad Genetics, Qiagen, Roche Diagnostics, Thermo Fisher Scientific, and Agilent.
Abbott Laboratories is a pharmaceutical company engaged in developing and marketing healthcare products. It also offers diagnostic systems, neuro-modulation devices, medical devices, and other products. The company provides these products under multiple brand names, including Similar, Oxepa, Alinity, and FreeStyle, among others. It offers products to consumers, wholesalers, retailers, healthcare facilities, government agencies, laboratories, and ambulatory surgery centers. Abbott operates across North America, Latin America, the Middle and Africa, and Asia-Pacific.

TABLE OF CONTENTS

1. GLOBAL COMPANION DIAGNOSTICS MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE COMPANION DIAGNOSTICS MARKET
2.2. KEY INSIGHTS
2.2.1. COMMERCIAL SUCCESS OF PRECISION MEDICINE TREATMENT
2.2.2. ADOPTION OF PREDICTIVE BIOMARKERS
2.2.3. FUSION OF COMPUTER SCIENCE AND BIOLOGY
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY BUYING IMPACT ANALYSIS
2.4.1. COST
2.4.2. AVAILABILITY
2.4.3. SENSITIVITY & SPECIFICITY
2.4.4. EFFICACY
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. REGULATORY FRAMEWORK
2.9. KEY MARKET STRATEGIES
2.9.1. ACQUISITIONS
2.9.2. PRODUCT LAUNCHES
2.9.3. CONTRACTS & AGREEMENTS
2.10. MARKET DRIVERS
2.10.1. INCREASE IN INCIDENCE OF MEDICATION REACTIONS
2.10.2. INCREASING PREVALENCE OF CANCER CASES AND FATALITIES
2.10.3. RISING PREVALENCE OF PRECISION MEDICINES
2.11. MARKET CHALLENGES
2.11.1. WEAK REIMBURSEMENT FRAMEWORK
2.11.2. COMMON CASES OF LEAKAGE IN ONCOLOGY COMPANION DIAGNOSTICS
2.12. MARKET OPPORTUNITY
2.12.1. ONGOING RESEARCH AND INVESTMENTS IN NEXT GENERATION GENE-SEQUENCING
3. GLOBAL COMPANION DIAGNOSTICS MARKET OUTLOOK – BY MECHANISM
3.1. IN-SITU HYBRIDIZATION
3.2. POLYMERASE CHAIN REACTION
3.3. IMMUNOHISTOCHEMISTRY
3.4. NEXT GENERATION SEQUENCING
3.5. OTHER MECHANISMS
4. GLOBAL COMPANION DIAGNOSTICS MARKET OUTLOOK – BY INDICATOR
4.1. ONCOLOGY
4.2. NEUROLOGY
4.3. INFECTIOUS DISEASES
4.4. OTHER INDICATORS
5. GLOBAL COMPANION DIAGNOSTICS MARKET OUTLOOK – BY CONSUMER
5.1. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
5.2. REFERENCE LABORATORIES
5.3. OTHER CONSUMERS
6. GLOBAL COMPANION DIAGNOSTICS MARKET OUTLOOK – BY COMMODITY
6.1. ASSAY KITS AND REAGENTS
6.2. SOFTWARE AND SERVICES
7. GLOBAL COMPANION DIAGNOSTICS MARKET – REGIONAL OUTLOOK
7.1. NORTH AMERICA
7.1.1. MARKET OUTLOOK BY MECHANISM
7.1.2. MARKET OUTLOOK BY INDICATOR
7.1.3. MARKET OUTLOOK BY CONSUMER
7.1.4. MARKET OUTLOOK BY COMMODITY
7.1.5. COUNTRY ANALYSIS
7.1.5.1. UNITED STATES
7.1.5.2. CANADA
7.2. EUROPE
7.2.1. MARKET OUTLOOK BY MECHANISM
7.2.2. MARKET OUTLOOK BY INDICATOR
7.2.3. MARKET OUTLOOK BY CONSUMER
7.2.4. MARKET OUTLOOK BY COMMODITY
7.2.5. COUNTRY ANALYSIS
7.2.5.1. UNITED KINGDOM
7.2.5.2. GERMANY
7.2.5.3. FRANCE
7.2.5.4. SPAIN
7.2.5.5. ITALY
7.2.5.6. POLAND
7.2.5.7. REST OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. MARKET OUTLOOK BY MECHANISM
7.3.2. MARKET OUTLOOK BY INDICATOR
7.3.3. MARKET OUTLOOK BY CONSUMER
7.3.4. MARKET OUTLOOK BY COMMODITY
7.3.5. COUNTRY ANALYSIS
7.3.5.1. CHINA
7.3.5.2. JAPAN
7.3.5.3. INDIA
7.3.5.4. SOUTH KOREA
7.3.5.5. ASEAN COUNTRIES
7.3.5.6. AUSTRALIA & NEW ZEALAND
7.3.5.7. REST OF ASIA-PACIFIC
7.4. LATIN AMERICA
7.4.1. MARKET OUTLOOK BY MECHANISM
7.4.2. MARKET OUTLOOK BY INDICATOR
7.4.3. MARKET OUTLOOK BY CONSUMER
7.4.4. MARKET OUTLOOK BY COMMODITY
7.4.5. COUNTRY ANALYSIS
7.4.5.1. BRAZIL
7.4.5.2. MEXICO
7.4.5.3. REST OF LATIN AMERICA
7.5. MIDDLE EAST AND AFRICA
7.5.1. MARKET OUTLOOK BY MECHANISM
7.5.2. MARKET OUTLOOK BY INDICATOR
7.5.3. MARKET OUTLOOK BY CONSUMER
7.5.4. MARKET OUTLOOK BY COMMODITY
7.5.5. COUNTRY ANALYSIS
7.5.5.1. UNITED ARAB EMIRATES
7.5.5.2. SAUDI ARABIA
7.5.5.3. TURKEY
7.5.5.4. SOUTH AFRICA
7.5.5.5. REST OF MIDDLE EAST & AFRICA
8. COMPETITIVE LANDSCAPE
8.1. ABBOTT LABORATORIES
8.2. ALMAC GROUP
8.3. ARUP LABORATORIES
8.4. BIOCARTIS
8.5. BIOMERIEUX
8.6. DANAHER CORPORATION
8.7. GE HEALTHCARE
8.8. GENOMIC HEALTH
8.9. ILLUMINA INC
8.10. MYRIAD GENETICS
8.11. QIAGEN
8.12. ROCHE DIAGNOSTICS
8.13. SYSMEX CORPORATION
8.14. THERMO FISHER SCIENTIFIC
8.15. AGILENT
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

LIST OF TABLES

TABLE 1: GLOBAL COMPANION DIAGNOSTICS MARKET, REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF CONTRACTS & AGREEMENTS
TABLE 6: NUMBER OF CANCER PATIENTS IN 2020
TABLE 7: GLOBAL COMPANION DIAGNOSTICS MARKET, OUTLOOK BY MECHANISM, 2022-2028 (IN $ MILLION)
TABLE 8: GLOBAL COMPANION DIAGNOSTICS MARKET, OUTLOOK BY INDICATOR, 2022-2028 (IN $ MILLION)
TABLE 9: GLOBAL COMPANION DIAGNOSTICS MARKET, OUTLOOK BY CONSUMER, 2022-2028 (IN $ MILLION)
TABLE 10: GLOBAL COMPANION DIAGNOSTICS MARKET, OUTLOOK BY COMMODITY, 2022-2028 (IN $ MILLION)
TABLE 11: GLOBAL COMPANION DIAGNOSTICS MARKET, REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY MECHANISM, 2022-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY INDICATOR, 2022-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY CONSUMER, 2022-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY COMMODITY, 2022-2028 (IN $ MILLION)
TABLE 16: NORTH AMERICA COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 17: EUROPE COMPANION DIAGNOSTICS MARKET, OUTLOOK BY MECHANISM, 2022-2028 (IN $ MILLION)
TABLE 18: EUROPE COMPANION DIAGNOSTICS MARKET, OUTLOOK BY INDICATOR, 2022-2028 (IN $ MILLION)
TABLE 19: EUROPE COMPANION DIAGNOSTICS MARKET, OUTLOOK BY CONSUMER, 2022-2028 (IN $ MILLION)
TABLE 20: EUROPE COMPANION DIAGNOSTICS MARKET, OUTLOOK BY COMMODITY, 2022-2028 (IN $ MILLION)
TABLE 21: EUROPE COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 22: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, OUTLOOK BY MECHANISM, 2022-2028 (IN $ MILLION)
TABLE 23: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, OUTLOOK BY INDICATOR, 2022-2028 (IN $ MILLION)
TABLE 24: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, OUTLOOK BY CONSUMER, 2022-2028 (IN $ MILLION)
TABLE 25: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, OUTLOOK BY COMMODITY, 2022-2028 (IN $ MILLION)
TABLE 26: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 27: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY MECHANISM, 2022-2028 (IN $ MILLION)
TABLE 28: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY INDICATOR, 2022-2028 (IN $ MILLION)
TABLE 29: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY CONSUMER, 2022-2028 (IN $ MILLION)
TABLE 30: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY COMMODITY, 2022-2028 (IN $ MILLION)
TABLE 31: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 32: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY MECHANISM, 2022-2028 (IN $ MILLION)
TABLE 33: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY INDICATOR, 2022-2028 (IN $ MILLION)
TABLE 34: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY CONSUMER, 2022-2028 (IN $ MILLION)
TABLE 35: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, OUTLOOK BY COMMODITY, 2022-2028 (IN $ MILLION)
TABLE 36: MIDDLE EAST AND AFRICA COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: MARKET ATTRACTIVENESS INDEX
FIGURE 2: INDUSTRY COMPONENTS
FIGURE 3: FDA FRAMEWORK
FIGURE 4: CDX LEAKAGE POINTS
FIGURE 5: GLOBAL COMPANION DIAGNOSTICS MARKET, OUTLOOK BY MECHANISM, 2021 & 2028 (IN %)
FIGURE 6: GLOBAL COMPANION DIAGNOSTICS MARKET, BY IN-SITU HYBRIDIZATION, 2022-2028 (IN $ MILLION)
FIGURE 7: GLOBAL COMPANION DIAGNOSTICS MARKET, BY POLYMERASE CHAIN REACTION, 2022-2028 (IN $ MILLION)
FIGURE 8: GLOBAL COMPANION DIAGNOSTICS MARKET, BY IMMUNOHISTOCHEMISTRY, 2022-2028 (IN $ MILLION)
FIGURE 9: GLOBAL COMPANION DIAGNOSTICS MARKET, BY NEXT GENERATION SEQUENCING, 2022-2028 (IN $ MILLION)
FIGURE 10: GLOBAL COMPANION DIAGNOSTICS MARKET, BY OTHER MECHANISMS, 2022-2028 (IN $ MILLION)
FIGURE 11: GLOBAL COMPANION DIAGNOSTICS MARKET, OUTLOOK BY INDICATOR, 2021 & 2028 (IN %)
FIGURE 12: GLOBAL COMPANION DIAGNOSTICS MARKET, BY ONCOLOGY, 2022-2028 (IN $ MILLION)
FIGURE 13: GLOBAL COMPANION DIAGNOSTICS MARKET, BY NEUROLOGY, 2022-2028 (IN $ MILLION)
FIGURE 14: GLOBAL COMPANION DIAGNOSTICS MARKET, BY INFECTIOUS DISEASES, 2022-2028 (IN $ MILLION)
FIGURE 15: GLOBAL COMPANION DIAGNOSTICS MARKET, BY OTHER INDICATORS, 2022-2028 (IN $ MILLION)
FIGURE 16: GLOBAL COMPANION DIAGNOSTICS MARKET, OUTLOOK BY CONSUMER, 2021 & 2028 (IN %)
FIGURE 17: GLOBAL COMPANION DIAGNOSTICS MARKET, BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 18: GLOBAL COMPANION DIAGNOSTICS MARKET, BY REFERENCE LABORATORIES, 2022-2028 (IN $ MILLION)
FIGURE 19: GLOBAL COMPANION DIAGNOSTICS MARKET, BY OTHER CONSUMERS, 2022-2028 (IN $ MILLION)
FIGURE 20: GLOBAL COMPANION DIAGNOSTICS MARKET, OUTLOOK BY COMMODITY, 2021 & 2028 (IN %)
FIGURE 21: GLOBAL COMPANION DIAGNOSTICS MARKET, BY ASSAY KITS AND REAGENTS, 2022-2028 (IN $ MILLION)
FIGURE 22: GLOBAL COMPANION DIAGNOSTICS MARKET, BY SOFTWARE AND SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 23: GLOBAL COMPANION DIAGNOSTICS MARKET, REGIONAL OUTLOOK, 2021 & 2028 (IN %)
FIGURE 24: NORTH AMERICA COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021
FIGURE 25: UNITED STATES COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: CANADA COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 27: EUROPE COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021
FIGURE 28: UNITED KINGDOM COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 29: GERMANY COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 30: FRANCE COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 31: SPAIN COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 32: ITALY COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 33: POLAND COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 34: REST OF EUROPE COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 35: ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021
FIGURE 36: CHINA COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 37: JAPAN COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 38: INDIA COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 39: SOUTH KOREA COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 40: ASEAN COUNTRIES COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 41: AUSTRALIA & NEW ZEALAND COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 42: REST OF ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 43: LATIN AMERICA COMPANION DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021
FIGURE 44: BRAZIL COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 45: MEXICO COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 46: REST OF LATIN AMERICA COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 47: MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET COUNTRY OUTLOOK, 2021
FIGURE 48: UNITED ARAB EMIRATES COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 49: SAUDI ARABIA COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 50: TURKEY COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 51: SOUTH AFRICA COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 52: REST OF MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET 2022-2028 (IN $ MILLION)

The post GLOBAL COMPANION DIAGNOSTICS MARKET 2022-2028 first appeared on CRI Report.

A report by CRIstates that the global vetronics market is expected to show an uptrend at a CAGR of 5.62% during the forecast period of 2022-2028.
The market is driven by factors such as the open architecture of the vetronics systems, advancements in battlefield technology and ongoing military modernization of the land-based vehicle inventory. The defense forces are expected to be modernized, updated and ready to respond to changes concerning developing technologies. Armies worldwide prioritize and update ground vehicles and their components, particularly their electronic systems, to provide soldiers with the most modern fighting platforms available. Future armies are projected to change the battlefield of the future due to the modernization of next-generation vehicles. On the contrary, the cut-offs in the defense budget, rising cost of raw materials and usability regulations are expected to impede the growth of the studied market.

REGIONAL OUTLOOK

The global vetronics market is studied across North America, Asia-Pacific, Europe, Latin America, and the Middle East and Africa.
North America dominates the vetronics market globally, and it is expected to maintain its stronghold until 2028. The demand for vetronics in the region has increased significantly due to efforts made by its military and administration to modernize its army and navy. Another element boosting the growth of the North American vetronics industry is the ongoing upgradation of outdated platforms. The Department of Defense and regional market players are investing heavily in R&D to upgrade its land-based fleet. Additionally, United States leads the region’s market with a share of 96.93% in 2021. This is due to the presence of more developed venture capital market in the country.

COMPETITIVE OUTLOOK

The esteemed players in the vetronics market include BAE Systems, Leonardo S.p.A, Thales Group, Lockheed Martin Corporation, Rheinmetall AG, Raytheon Technologies, General Dynamics Corporation, Saab AB, L3Harris Technologies, and Curtiss-Wright.
Founded in 1929, Curtiss-Wright is a precision component and engineered product manufacturer and services distributor for the aerospace, defense, general industrial, and power generation sectors. It is headquartered in the United States and operates businesses and factories worldwide. Its three operating segments are Aerospace and Industrial, Defense Electronics, and Naval and Power. In addition to producing industrial vehicle items, the corporation also provides military assistance and equipment for the air, land, and marine divisions. Further, it also provides hardware, pumps, valves, fastening systems, specialist containment doors, and other items.

TABLE OF CONTENTS

1. GLOBAL VETRONICS MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE VETRONICS MARKET
2.2. KEY INSIGHTS
2.2.1. GROWTH OF THE VETRONICS MARKET IN THE ASIA-PACIFIC REGION (INDIA)
2.2.2. GROWING INVESTMENTS IN HYBRID MILITARY VEHICLES
2.2.3. RISING MILITARY LAND-VEHICLE INVENTORY
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. INDUSTRY COMPONENTS
2.6.1. COMPONENT PROVIDERS
2.6.2. SYSTEM MANUFACTURERS/OEMs
2.6.3. DISTRIBUTION CHANNELS
2.6.4. END-USERS
2.6.5. AFTERMARKET SERVICES
2.7. KEY MARKET STRATEGY
2.7.1. ACQUISITIONS
2.8. MARKET DRIVERS
2.8.1. OPEN ARCHITECTURE OF VETRONICS SYSTEMS
2.8.2. ONGOING MILITARY MODERNIZATION OF LAND-BASED VEHICLE INVENTORY
2.8.3. ADVANCEMENTS IN BATTLEFIELD TECHNOLOGY
2.9. MARKET CHALLENGES
2.9.1. CUT-OFFS IN DEFENSE BUDGET
2.9.2. RISING COST OF RAW MATERIALS
2.9.3. USABILITY REGULATIONS
2.10. MARKET OPPORTUNITIES
2.10.1. INVESTMENTS IN RESEARCH & DEVELOPMENT
2.10.2. GROWING VETRONICS MARKET IN THE UNITED STATES
3. GLOBAL VETRONICS MARKET OUTLOOK – LAND-BASED FLEET TYPE
3.1. TANKS
3.2. ARMORED VEHICLES
3.3. ARTILLERY
3.4. ROCKET PROJECTORS
4. GLOBAL VETRONICS MARKET OUTLOOK – BY COMPONENT
4.1. ELECTRONIC WARFARE & C4 SYSTEMS
4.2. NAVIGATION SYSTEMS
4.3. POWER SYSTEMS
4.4. VEHICLE PROTECTION SYSTEMS
5. GLOBAL VETRONICS MARKET OUTLOOK – BY VERTICAL
5.1. DEFENSE
5.2. HOMELAND SECURITY
6. GLOBAL VETRONICS MARKET – REGIONAL OUTLOOK
6.1. NORTH AMERICA
6.1.1. MARKET OUTLOOK BY LAND-BASED FLEET TYPE
6.1.2. MARKET OUTLOOK BY COMPONENT
6.1.3. MARKET OUTLOOK BY VERTICAL
6.1.4. COUNTRY ANALYSIS
6.1.4.1. UNITED STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET OUTLOOK BY LAND-BASED FLEET TYPE
6.2.2. MARKET OUTLOOK BY COMPONENT
6.2.3. MARKET OUTLOOK BY VERTICAL
6.2.4. COUNTRY ANALYSIS
6.2.4.1. UNITED KINGDOM
6.2.4.2. GERMANY
6.2.4.3. FRANCE
6.2.4.4. SPAIN
6.2.4.5. ITALY
6.2.4.6. POLAND
6.2.4.7. GREECE
6.2.4.8. REST OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET OUTLOOK BY LAND-BASED FLEET TYPE
6.3.2. MARKET OUTLOOK BY COMPONENT
6.3.3. MARKET OUTLOOK BY VERTICAL
6.3.4. COUNTRY ANALYSIS
6.3.4.1. CHINA
6.3.4.2. JAPAN
6.3.4.3. INDIA
6.3.4.4. SOUTH KOREA
6.3.4.5. THAILAND
6.3.4.6. VIETNAM
6.3.4.7. TAIWAN
6.3.4.8. REST OF ASIA-PACIFIC
6.4. LATIN AMERICA
6.4.1. MARKET OUTLOOK BY LAND-BASED FLEET TYPE
6.4.2. MARKET OUTLOOK BY COMPONENT
6.4.3. MARKET OUTLOOK BY VERTICAL
6.4.4. COUNTRY ANALYSIS
6.4.4.1. BRAZIL
6.4.4.2. MEXICO
6.4.4.3. ARGENTINA
6.4.4.4. VENEZUELA
6.4.4.5. REST OF LATIN AMERICA
6.5. MIDDLE EAST AND AFRICA
6.5.1. MARKET OUTLOOK BY LAND-BASED FLEET TYPE
6.5.2. MARKET OUTLOOK BY COMPONENT
6.5.3. MARKET OUTLOOK BY VERTICAL
6.5.4. COUNTRY ANALYSIS
6.5.4.1. EGYPT
6.5.4.2. TURKEY
6.5.4.3. IRAN
6.5.4.4. ISRAEL
6.5.4.5. SAUDI ARABIA
6.5.4.6. ALGERIA
6.5.4.7. MOROCCO
6.5.4.8. REST OF MIDDLE EAST & AFRICA
7. COMPETITIVE LANDSCAPE
7.1. CURTISS-WRIGHT
7.2. BAE SYSTEMS
7.3. THALES GROUP
7.4. GENERAL DYNAMICS CORPORATION
7.5. LOCKHEED MARTIN CORPORATION
7.6. RHEINMETALL AG
7.7. RAYTHEON TECHNOLOGIES
7.8. L3HARRIS TECHNOLOGIES
7.9. SAAB AB
7.10. LEONARDO S.P.A
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY

LIST OF TABLES

TABLE 1: GLOBAL VETRONICS MARKET, REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: GLOBAL VETRONICS MARKET, BY LAND-BASED FLEET TYPE, 2022-2028 (IN $ MILLION)
TABLE 5: GLOBAL VETRONICS MARKET, BY COMPONENT, 2022-2028 (IN $ MILLION)
TABLE 6: GLOBAL VETRONICS MARKET, BY VERTICAL, 2022-2028 (IN $ MILLION)
TABLE 7: GLOBAL VETRONICS MARKET, REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA VETRONICS MARKET, BY LAND-BASED FLEET TYPE, 2022-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA VETRONICS MARKET, BY COMPONENT, 2022-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA VETRONICS MARKET, BY VERTICAL, 2022-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA VETRONICS MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 12: EUROPE VETRONICS MARKET, BY LAND-BASED FLEET TYPE, 2022-2028 (IN $ MILLION)
TABLE 13: EUROPE VETRONICS MARKET, BY COMPONENT, 2022-2028 (IN $ MILLION)
TABLE 14: EUROPE VETRONICS MARKET, BY VERTICAL 2022-2028 (IN $ MILLION)
TABLE 15: EUROPE VETRONICS MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 16: ASIA-PACIFIC VETRONICS MARKET, BY LAND-BASED FLEET TYPE, 2022-2028 (IN $ MILLION)
TABLE 17: ASIA-PACIFIC VETRONICS MARKET, BY COMPONENT, 2022-2028 (IN $ MILLION)
TABLE 18: ASIA-PACIFIC VETRONICS MARKET, BY VERTICAL, 2022-2028 (IN $ MILLION)
TABLE 19: ASIA-PACIFIC VETRONICS MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 20: LATIN AMERICA VETRONICS MARKET, BY LAND-BASED FLEET TYPE, 2022-2028 (IN $ MILLION)
TABLE 21: LATIN AMERICA VETRONICS MARKET, BY COMPONENT, 2022-2028 (IN $ MILLION)
TABLE 22: LATIN AMERICA VETRONICS MARKET, BY VERTICAL, 2022-2028 (IN $ MILLION)
TABLE 23: LATIN AMERICA VETRONICS MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 24: MIDDLE EAST AND AFRICA VETRONICS MARKET, BY LAND-BASED FLEET TYPE, 2022-2028 (IN $ MILLION)
TABLE 25: MIDDLE EAST AND AFRICA VETRONICS MARKET, BY COMPONENT, 2022-2028 (IN $ MILLION)
TABLE 26: MIDDLE EAST AND AFRICA VETRONICS MARKET, BY VERTICAL, 2022-2028 (IN $ MILLION)
TABLE 27: MIDDLE EAST AND AFRICA VETRONICS MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: MARKET ATTRACTIVENESS INDEX
FIGURE 2: GLOBAL VETRONICS MARKET, BY LAND-BASED FLEET TYPE, 2021 & 2028 (IN %)
FIGURE 3: GLOBAL VETRONICS MARKET, BY TANKS, 2022-2028 (IN $ MILLION)
FIGURE 4: GLOBAL VETRONICS MARKET, BY ARMORED VEHICLES, 2022-2028 (IN $ MILLION)
FIGURE 5: GLOBAL VETRONICS MARKET, BY ARTILLERY, 2022-2028 (IN $ MILLION)
FIGURE 6: GLOBAL VETRONICS MARKET, BY ROCKET PROJECTORS, 2022-2028 (IN $ MILLION)
FIGURE 7: GLOBAL VETRONICS MARKET, BY COMPONENT, 2021 & 2028 (IN %)
FIGURE 8: GLOBAL VETRONICS MARKET, BY ELECTRONIC WARFARE & C4 SYSTEMS, 2022-2028 (IN $ MILLION)
FIGURE 9: GLOBAL VETRONICS MARKET, BY NAVIGATION SYSTEMS, 2022-2028 (IN $ MILLION)
FIGURE 10: GLOBAL VETRONICS MARKET, BY POWER SYSTEMS, 2022-2028 (IN $ MILLION)
FIGURE 11: GLOBAL VETRONICS MARKET, BY VEHICLE PROTECTION SYSTEMS, 2022-2028 (IN $ MILLION)
FIGURE 12: GLOBAL VETRONICS MARKET, BY VERTICAL, 2021 & 2028 (IN %)
FIGURE 13: GLOBAL VETRONICS MARKET, BY DEFENSE, 2022-2028 (IN $ MILLION)
FIGURE 14: GLOBAL VETRONICS MARKET, BY HOMELAND SECURITY, 2022-2028 (IN $ MILLION)
FIGURE 15: GLOBAL VETRONICS MARKET, REGIONAL OUTLOOK, 2021 & 2028 (IN %)
FIGURE 16: NORTH AMERICA VETRONICS MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 17: UNITED STATES VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 18: CANADA VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 19: EUROPE VETRONICS MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 20: UNITED KINGDOM VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 21: GERMANY VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 22: FRANCE VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: SPAIN VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: ITALY VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: POLAND VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: GREECE VETRONICS MARKET, 2022-2028 (IN $ MILLION)
FIGURE 27: REST OF EUROPE VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 28: ASIA-PACIFIC VETRONICS MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 29: CHINA VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 30: JAPAN VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 31: INDIA VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 32: SOUTH KOREA VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 33: THAILAND VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 34: VIETNAM VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 35: TAIWAN VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 36: REST OF ASIA-PACIFIC VETRONICS MARKET, 2022-2028 (IN $ MILLION)
FIGURE 37: LATIN AMERICA VETRONICS MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 38: BRAZIL VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 39: MEXICO VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 40: ARGENTINA VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 41: VENEZUELA VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 42: REST OF LATIN AMERICA VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 43: MIDDLE EAST AND AFRICA VETRONICS MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 44: EGYPT VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 45: TURKEY VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 46: IRAN VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 47: ISRAEL VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 48: SAUDI ARABIA VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 49: ALGERIA VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 50: MOROCCO VETRONICS MARKET 2022-2028 (IN $ MILLION)
FIGURE 51: REST OF MIDDLE EAST & AFRICA VETRONICS MARKET 2022-2028 (IN $ MILLION)

The post GLOBAL VETRONICS MARKET 2022-2028 first appeared on CRI Report.